Differential expression of αv integrins in K1735 melanoma cells

Invasion and Metastasis

Volumn 18, Issue 1, 1999, Pages 1-14

  Li, Xiaowu ^a   Chen, Bing ^a   Blystone, Scott D ^b   McHugh, Kevin P ^c   Ross, F Patrick ^c   Ramos, Daniel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential expression, v integrins; Extracellular matrix; Melanoma cells

Indexed keywords

BLOCKING ANTIBODY; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; FIBRONECTIN; INTEGRIN; VITRONECTIN; ALPHAVBETA5 INTEGRIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; C3H MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; CELL CULTURE; CELL MOTION; GENETIC TRANSDUCTION; GENETICS; MELANOMA; METABOLISM; NUCLEIC ACID PROBE; PATHOLOGY; RETROVIRUS; SERODIAGNOSIS;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); CELL ADHESION; CELL MOVEMENT; INTEGRINS; MELANOMA; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PRECIPITIN TESTS; RECEPTORS, VITRONECTIN; RETROVIRIDAE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032243158     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024494     Document Type: Article

References (23)

1. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Heryln M, Buck C: Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res 1990;50: 6757-6764.
2. Pytela R, Pierschbacher MD, Ruoslahti E: A 125/115 kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA 1985;82:5766-5770.
3. Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJ: Role of the αvβ3 integrin in human melanoma invasion. Proc Natl Acad Sci USA 1992;89:1557-1561.
4. de Boer HC, de Groot PG, Bouma BN, Preissner KT: Ternary vitronectin-thrombin-antithrombin III complexes in human plasma: Detection and mode of association. J Biol Chem 1993;268:1279-1283.
5. Brooks PC, Clark RAF, Cheresh DA: Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994;264:569-571.
6. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-1164.
7. Felding-Habermann B, Mueller B, Romerdahl C, Cheresh DA: Involvement of integrin αv gene expression in human melanoma tumorigenicity. J Clin Invest 1992;89: 2018-2022.
8. Yun Z, Mentor DG, Nicolson G: Involvement of integrin αvβ3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma. Cancer Res 1996;56: 3103-3111.
9. Buck CA, Horwitz AF: Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol 1987;3:179-205.
10. Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR: Integrin expression in human melanoma cell lines: Heterogeneity of vitronectin receptor composition and function. Int J Cancer 1991;49: 924-931.
11. Danen EH, Jansen KF, Van Kraats AA, Cornelissen IM, Ruiter DJ, Van Muijen GN: αv-integrins in human melanoma: Gain of αvβ3 and loss of αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice. Int J Cancer 1995;61:491-496.
12. 3 subunit for carcinoma cell spreading or migration on vitronectin and fibronectin. J Cell Biol 1992;117: 1101-1107.
13. Pasqualini R, Bodorova J, Ye S, Hemler ME: A study of the structure, function and distribution of beta 5 integrins using novel anti-beta 5 monoclonal antibodies. J Cell Sci 1994;105:101-111.
14. Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 1977;197:26-35.
15. Ramos DM, Chen BL, Boylen KB, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L, Pytela R: Stromal fibroblasts influence oral squamous cell carcinoma cell interactions with tenascin-C. Int J Cancer 1997;72:369-376.
16. Eglitis MA, Kantoff PW, Jolly JD, Jones JB, Anderson WF, Lothrop CD: Gene transfer into hematopoietic progenitor cells from normal and cyclic hematopoietic dogs using retroviral vectors. Blood 1988;71: 717-722.
17. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
18. Mortarini R, Anichini A: From adhesion to signaling: Roles of integrins in the biology of human melanoma. Melanoma Res 1993;3:87-97.
19. Smith JW, Vestal DJ, Irwin SV, Burke TA, Cheresh DA: Purification and functional characterization of integrin αvβ: An adhesion receptor for vitronectin. J Biol Chem 1990;265:11008-11013.
20. Blystone SD, Lindberg FP, Williams MP, McHugh KP, Brown EJ: Inducible tyrosine phosphorylation of the β3 integrin requires the αv integrin cytoplasmic tail. J Biol Chem 1996;271:31458-31462.
21. Tahiliani PD, Singh L, Auer KL, La Flamme SE: The role of conserved amino acid motifs within the integrin α3 cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J Biol Chem 1997;272: 7892-7898.
22. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA: Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 1992;117:1101-1107.
23. Milner R, french-Constant C: A developmental analysis of oligodendroglial integrins in primary cells: Changes in αv-associated β subunits during differentiation. Development 1994;120:3497-3506.